Faraday Future Appoints Edward Darwick as New Head of Finance Operations
Company recaps key highlights from Q1 earnings results reported on May 11, 2023. LOS ANGELES–(BUSINESS…
Year: 2023
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications SAN DIEGO, May 15,…
ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® for the Treatment…
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
The Company is recognized for its commitment to employees’ well-being MALVERN, Pa., May 15, 2023…
Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson
Appointment to Enhance Board’s Expertise Across Investments, Business Development and Capital Markets Kelly Anderson Hillstream BioPharma…
AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update
– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones…
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2023 and Provides Corporate Update
Upcoming Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010,…
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
– Top-line data from Phase 2a DUET clinical trial of TERN-501 (THR-β agonist) in NASH…
Celldex Therapeutics Presents Positive Preclinical Data from TSLP/SCF Bispecific Antibody Program CDX-622 at IMMUNOLOGY2023™
HAMPTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced preclinical…
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
– Data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, for patients…
ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
YONKERS, N.Y., May 15, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Nuvectis Pharma Announces FDA Clearance of NXP900 IND
Fort Lee, NJ, May 15, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
9 subjects enrolled into the OPMD clinical development program HAYWARD, Calif., May 15, 2023 (GLOBE…
Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer
SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Company to host Investor Update call on June 14, 2023 to review and discuss the…
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
BOTHELL, Wash., May 15, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the…
InspireMD Announces Private Placement of Up to $113.6 Million
Led by Marshall Wace with participation from OrbiMed, Rosalind, Nantahala, Soleus, Velan and certain InspireMD Board members…
Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study
Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries SANTA CLARA, Calif., May…
Locanabio Announces Equity Investment from CureDuchenne Ventures to Support Development of snRNA Exon Skipping Approach for Duchenne Muscular Dystrophy (DMD)
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Locanabio, Inc., a genetic medicines company developing…
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
End-of-Phase 2 Meeting with FDA Anticipated in 2H 2023 to Confirm Phase 3 Regulatory Path…